[PTGX] YoY Annual Result on 31-Dec-2019 [#FY]

Stock
[PTGX] Protagonist Therapeutics, Inc.
Announcement Date
10-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#FY]
Profit Trend
YoY- -98.30%
Quarter Report
PTGX's Result
PTGX's Financial Summary
View:
Show?
Annual Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 26,581 27,357 28,628 231 30,925 20,063 0 -
PBT -127,393 -125,551 -64,845 -77,878 -39,723 -36,957 -37,177 22.77%
Tax -3,980 -2,924 1,305 -691 -799 -406 4,160 -
NP -123,413 -122,627 -66,150 -77,187 -38,924 -36,957 -37,177 22.12%
Tax Rate - - - - - - - -
Total Cost 149,994 149,984 94,778 77,418 69,849 57,020 37,177 26.15%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -464.29 -448.25 -231.07 -33,414.29 -125.87 -184.20 0.00 -
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -2.52 -2.65 -1.92 -2.98 -1.74 -2.09 -5.72 -12.76%
EPS Diluted -2.52 -2.65 -1.92 -2.98 -1.74 -2.09 -5.72 -12.76%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.